continuous-glucose-monitoring
(5)
MiniMed and the five-minute fix
A pump, a sensor, and a small correction every five minutes. MiniMed’s long experiment is about giving people with diabetes less work to do.
The Health Company Hiding in Your Kitchen, Your Lab and Under Your Skin
Abbott built a $44.3 billion business by showing up everywhere health becomes measurable - from a breakfast shake to a glucose curve to a repaired heart valve. Its breadth is the strategy, and the complication.
Ultrahuman
Ultrahuman is a Bengaluru-founded health-technology company building a subscription-free wearable and diagnostics ecosystem centered on its Ring AIR and Ring PRO smart rings. Beyond the ring, the company sells a continuous glucose monitor (M1), a home environmental sensor (Ultrahuman Home) and a blood-biomarker service (Blood Vision), stitching them into a single app that turns sleep, movement, metabolic and recovery data into personalized nudges. Founded in 2019 by Mohit Kumar and Vatsal Singhal, it is now the second-largest smart-ring maker by units sold and is expanding US manufacturing to challenge market leader Oura.
Luna Diabetes
Luna Diabetes (Luna Health Inc.) is a San Diego medical device company building the first automated insulin delivery system designed for the more than 90% of insulin-requiring people who dose with an insulin pen rather than a full-time pump. Its flagship product, Luna, pairs what the company calls the world's smallest insulin patch pump with a fully closed-loop algorithm to automate micro-doses of rapid-acting insulin overnight, when most of the glucose benefit from pump therapy occurs. Founded in 2020 by diabetes-industry veterans John Sjolund, Jon Brilliant and Sean Saint, the company raised a $23.6M Series A in August 2025 and is running a pivotal clinical trial using Time in Range as its primary endpoint.
Twin Health
Twin Health builds a Whole Body Digital Twin - a real-time AI model of each member's metabolism that learns from wearable sensors, labs, and daily behavior to reverse type 2 diabetes, obesity, and other chronic metabolic conditions without long-term reliance on medications.